PACS Group, Inc.

PACS NYSE SEC CIK 2001184
Follow PACS Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.5B +11.4% vs same quarter last year
Net income $60.8M +16.1% vs same quarter last year
EPS, diluted $0.37 +15.6% vs same quarter last year
Operating cash flow $211.2M +3.1% vs same quarter last year
Revenue by quarter
$1.2B
$1.3B
$1.3B
$1.3B
$1.4B
$1.4B
$1.4B
$1.5B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income5 fiscal years
  • Revenue
  • Net income
$0$2B$4B$6BFY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$5.3B$191.5M
FY24$4.1B$55.8M
FY23$3.1B$112.9M
FY22$2.4B$150.5M
FY21--
MarginsShare of revenue
  • Operating margin
  • Net margin
0%2.5%5%7.5%10%FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY255.9%3.6%
FY243%1.4%
FY236.7%3.6%
FY229.6%6.3%
FY21--
Returned to shareholdersDividends paid and shares bought back
$0$25M$50M$75M$100MFY21FY22FY23FY24FY25
Show the numbers
YearDividends
FY25$0
FY24$33.7M
FY23$80.4M
FY22$60.3M
FY21-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • PACS
  • Healthcare median
−100%−75%−50%−25%0%25%FY21FY22FY23FY24FY25
Show the numbers
YearPACSHealthcare median
FY253.6%−30.6%
FY241.4%−47%
FY233.6%−58%
FY226.3%−80.4%
FY21-−71.9%